Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania

Abramson Cancer Center at University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Abramson Cancer Center at University of Pennsylvania has participated in 25 clinical trials with 13 currently active.

Therapeutic areas: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome.

Sponsors: Abramson Cancer Center at Penn Medicine, Synta Pharmaceuticals Corp., Ryan Carey.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center at University of Pennsylvania?

Abramson Cancer Center at University of Pennsylvania has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center at University of Pennsylvania conducted?

Abramson Cancer Center at University of Pennsylvania has 25 clinical trials on record, with 13 currently active. Their work covers Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome.

Is Abramson Cancer Center at University of Pennsylvania accredited by Crixeo Clinical Trials?

Abramson Cancer Center at University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center at University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.